Litcius/Paper detail

CCK2R antagonists: from SAR to clinical trials

Doroteja Novak, Marko Anderluh, Petra Kolenc Peitl

2020Drug Discovery Today20 citationsDOI

Topics & Concepts

AntagonistClinical trialDrug discoveryGastrinMedicinePharmacologyBioinformaticsReceptorBiologyInternal medicineSecretionNeuropeptides and Animal PhysiologyNeuroendocrine Tumor Research AdvancesPeptidase Inhibition and Analysis
CCK2R antagonists: from SAR to clinical trials | Litcius